Late-breaking KEYNOTE-B15 data show KEYTRUDA ® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) significantly improved event-free survival, overall survival and pathologic complete response ...

Belushi spent the final hours of his life in the company of some of Hollywood’s biggest names. After leaving On the Rox and ...

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...

Pfizer Inc. and Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced positive results from the Phase 3 EV-304 clinical trial (also known as KEYNOTE-B15) for ...

American Oncology Network (AON) partner practice Fort Wayne Medical Oncology and Hematology (FWMOH), a trusted provider of cancer care in northeastern Indiana since 1977, today announced an expansion ...

Started in 2021, Cytokind describes itself as 'the global leader in using UVB light to treat immune disorders and improve survival and the quality of life for patients' ...

What's the wildest thing you've ever seen in the emergency room?

Timothy McCarty, 64, knows he hasn’t taken the best care of himself. He has been smoking since he was 15 – everyone did back ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced KEYTRUDA® (pembrolizumab) plus Padcev ® (enfortumab vedotin-ejfv) reduced the risk of event-free survival (EFS) ...

Regulator recommends durvalumab as first perioperative IO option for muscle‑invasive disease AstraZeneca has received a positive recommendation from the National Institute for Health and Care ...

Whether you are struggling with a severe stomach ache or you are celebrating a new pregnancy, a doctor's firstcall is often an ultrasound. We have all been there - sitting in a waiting room holding ...

LIKE many people, Joanna Ferguson found staying slim in her twenties easy – but struggled in her 40s. At 47, the mum-of-two ...